We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

43 hedge funds and large institutions have $61.9M invested in Assembly Biosciences in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more capital invested

Capital invested by funds: $61.1M → $61.9M (+$747K)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

7% less funds holding

Funds holding: 46 → 43 (-3)

18% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 17

25% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 12

Holders
43
Holders Change
-3
Holders Change %
-6.52%
% of All Funds
1.15%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
14
Increased
9
Reduced
12
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
EC
EcoR1 Capital
California
+$4.62M
2
ACA
Avoro Capital Advisors
New York
+$1.43M
3
ACP
Acuta Capital Partners
California
+$1.23M
4
Millennium Management
Millennium Management
New York
+$499K
5
SM
Sabby Management
Florida
+$494K

Top Sellers

1
VAM
Visium Asset Management
New York
-$8.58M
2
BFA
BlackRock Fund Advisors
California
-$1.87M
3
State Street
State Street
Massachusetts
-$799K
4
Northern Trust
Northern Trust
Illinois
-$742K
5
BIT
BlackRock Institutional Trust
California
-$541K
Name Holding Trade Value Shares
Change 		Change in
Stake
EC
1
EcoR1 Capital
California
$16.3M +$4.62M +70,405 +40%
Jennison Associates
2
Jennison Associates
New York
$11.3M -$10.8K -164 -0.1%
O
3
OrbiMed
New York
$7.75M – – –
PA
4
Perceptive Advisors
New York
$4.41M – – –
QF
5
QVT Financial
New York
$3.74M +$366K +5,575 +9%
Vanguard Group
6
Vanguard Group
Pennsylvania
$2.41M -$201K -3,063 -8%
Millennium Management
7
Millennium Management
New York
$2.36M +$499K +7,601 +27%
RSCM
8
Rock Springs Capital Management
Maryland
$2.17M – – –
PI
9
Putnam Investments
Massachusetts
$2.05M – – –
BIT
10
BlackRock Institutional Trust
California
$1.47M -$541K -8,240 -27%
ACA
11
Avoro Capital Advisors
New York
$1.45M +$1.43M +21,749 New
BBA
12
Baker Bros. Advisors
New York
$1.39M – – –
ACP
13
Acuta Capital Partners
California
$1.25M +$1.23M +18,787 New
SM
14
Sabby Management
Florida
$502K +$494K +7,530 New
Geode Capital Management
15
Geode Capital Management
Massachusetts
$401K -$84.3K -1,284 -18%
PP
16
Paloma Partners
Connecticut
$314K +$310K +4,717 New
CS
17
Credit Suisse
Switzerland
$273K +$212K +3,228 +371%
Jacobs Levy Equity Management
18
Jacobs Levy Equity Management
New Jersey
$264K -$20.3K -309 -7%
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$230K – – –
William Blair & Company
20
William Blair & Company
Illinois
$227K – – –
Northern Trust
21
Northern Trust
Illinois
$220K -$742K -11,310 -77%
DCM
22
Dialectic Capital Management
Connecticut
$219K -$94.9K -1,446 -31%
BFA
23
BlackRock Fund Advisors
California
$215K -$1.87M -28,560 -90%
Goldman Sachs
24
Goldman Sachs
New York
$136K +$134K +2,035 New
Susquehanna International Group
25
Susquehanna International Group
Pennsylvania
$136K +$134K +2,044 New
1
2 3

ASMB Hedge Fund Activity: Q2 2016 in Review

43 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q2 2016, worth a combined $61.9M — up 1.2% from $61.1M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of ASMB and 14 opened new positions — a net loss of 3 holders — while 12 trimmed existing stakes and 9 added.

The largest buyer was EcoR1 Capital, adding an estimated $4.62M. The largest seller was Visium Asset Management, exiting entirely with an estimated $8.58M sold.

  • 43 institutional investors held Assembly Biosciences (ASMB) as of Q2 2016, down from 46 in Q1 2016.
  • Funds reported $61.9M of Assembly Biosciences stock for Q2 2016, up 1.2% quarter-over-quarter.
  • 14 funds opened new Assembly Biosciences positions in Q2 2016 and 17 closed out, a net change of -3 holders.
  • The largest Assembly Biosciences buyer in Q2 2016 was EcoR1 Capital, an estimated $4.62M added.
  • The largest Assembly Biosciences seller in Q2 2016 was Visium Asset Management, an estimated $8.58M sold.

Based on aggregated 13F filings for Q2 2016.